Sintx Technologies, Inc. (SINT)
USD 2.01
(-19.6%)
USD 2.01
(-19.6%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 2.62 Million USD | 337.1% |
| 2022 | 601 Thousand USD | -0.83% |
| 2021 | 606 Thousand USD | 2.02% |
| 2020 | 594 Thousand USD | -13.79% |
| 2019 | 689 Thousand USD | 625.26% |
| 2018 | 95 Thousand USD | -99.15% |
| 2017 | 11.22 Million USD | -26.26% |
| 2016 | 15.22 Million USD | -21.73% |
| 2015 | 19.45 Million USD | -14.55% |
| 2014 | 22.76 Million USD | 2.02% |
| 2013 | 22.31 Million USD | -3.26% |
| 2012 | 23.06 Million USD | 13.84% |
| 2011 | 20.26 Million USD | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q1 | 687 Thousand USD | -23.84% |
| 2024 Q2 | 859 Thousand USD | 25.04% |
| 2023 Q4 | 902 Thousand USD | 33.04% |
| 2023 FY | 2.62 Million USD | 337.1% |
| 2023 Q1 | 240 Thousand USD | -2.83% |
| 2023 Q2 | 235 Thousand USD | -2.08% |
| 2023 Q3 | 678 Thousand USD | 188.51% |
| 2022 Q1 | 101 Thousand USD | -38.79% |
| 2022 Q2 | 80 Thousand USD | -20.79% |
| 2022 Q3 | 173 Thousand USD | 116.25% |
| 2022 Q4 | 247 Thousand USD | 42.77% |
| 2022 FY | 601 Thousand USD | -0.83% |
| 2021 Q3 | 239 Thousand USD | 136.63% |
| 2021 Q1 | 101 Thousand USD | -12.93% |
| 2021 Q2 | 101 Thousand USD | 0.0% |
| 2021 FY | 606 Thousand USD | 2.02% |
| 2021 Q4 | 165 Thousand USD | -30.96% |
| 2020 FY | 594 Thousand USD | -13.79% |
| 2020 Q1 | 207 Thousand USD | -17.86% |
| 2020 Q2 | 204 Thousand USD | -1.45% |
| 2020 Q3 | 66 Thousand USD | -67.65% |
| 2020 Q4 | 116 Thousand USD | 75.76% |
| 2019 Q2 | 167 Thousand USD | 72.16% |
| 2019 Q4 | 252 Thousand USD | 45.66% |
| 2019 FY | 689 Thousand USD | 625.26% |
| 2019 Q1 | 97 Thousand USD | 2.11% |
| 2019 Q3 | 173 Thousand USD | 3.59% |
| 2018 Q1 | 2.29 Million USD | -5.88% |
| 2018 FY | 95 Thousand USD | -99.15% |
| 2018 Q3 | - USD | -100.0% |
| 2018 Q4 | 95 Thousand USD | 0.0% |
| 2018 Q2 | 2.03 Million USD | -11.0% |
| 2017 Q1 | 2.62 Million USD | -28.01% |
| 2017 FY | 11.22 Million USD | -26.26% |
| 2017 Q4 | 2.43 Million USD | -17.66% |
| 2017 Q3 | 2.95 Million USD | -7.86% |
| 2017 Q2 | 3.2 Million USD | 22.02% |
| 2016 Q1 | 4.17 Million USD | -18.1% |
| 2016 FY | 15.22 Million USD | -21.73% |
| 2016 Q4 | 3.65 Million USD | 8.11% |
| 2016 Q2 | 4.02 Million USD | -3.59% |
| 2016 Q3 | 3.37 Million USD | -16.03% |
| 2015 FY | 19.45 Million USD | -14.55% |
| 2015 Q4 | 5.09 Million USD | 5.38% |
| 2015 Q3 | 4.83 Million USD | 1.15% |
| 2015 Q2 | 4.78 Million USD | 0.78% |
| 2015 Q1 | 4.74 Million USD | -7.92% |
| 2014 Q1 | 5.78 Million USD | 1.22% |
| 2014 FY | 22.76 Million USD | 2.02% |
| 2014 Q4 | 5.15 Million USD | -14.12% |
| 2014 Q3 | 5.99 Million USD | 2.78% |
| 2014 Q2 | 5.83 Million USD | 0.97% |
| 2013 Q1 | 5.25 Million USD | -11.55% |
| 2013 Q3 | 5.29 Million USD | -12.47% |
| 2013 Q4 | 5.71 Million USD | 7.78% |
| 2013 Q2 | 6.05 Million USD | 15.23% |
| 2013 FY | 22.31 Million USD | -3.26% |
| 2012 Q3 | 5.7 Million USD | 0.0% |
| 2012 FY | 23.06 Million USD | 13.84% |
| 2012 Q4 | 5.93 Million USD | 4.1% |
| 2011 FY | 20.26 Million USD | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Accelerate Diagnostics, Inc. | 12.05 Million USD | 78.215% |
| BrainsWay Ltd. | 31.78 Million USD | 91.735% |
| Cerus Corporation | 156.36 Million USD | 98.32% |
| Envoy Medical, Inc. | 316 Thousand USD | -731.329% |
| electroCore, Inc. | 16.03 Million USD | 83.612% |
| Helius Medical Technologies, Inc. | 644 Thousand USD | -307.919% |
| IceCure Medical Ltd | 3.22 Million USD | 18.644% |
| Inogen, Inc. | 315.66 Million USD | 99.168% |
| OrthoPediatrics Corp. | 148.73 Million USD | 98.234% |
| Lucid Diagnostics Inc. | 2.42 Million USD | -8.196% |
| Monogram Orthopaedics, Inc. | 364.99 Thousand USD | -619.728% |
| MaxCyte, Inc. | 41.28 Million USD | 93.637% |
| NeuroOne Medical Technologies Corporation | 1.95 Million USD | -34.55% |
| Nexalin Technology, Inc. | 110.74 Thousand USD | -2272.052% |
| Orthofix Medical Inc. | 746.64 Million USD | 99.648% |
| PAVmed Inc | 2.45 Million USD | -7.137% |
| Rapid Micro Biosystems, Inc. | 22.51 Million USD | 88.334% |
| RxSight, Inc. | 89.07 Million USD | 97.051% |
| Sight Sciences, Inc. | 81.05 Million USD | 96.759% |
| SI-BONE, Inc. | 138.88 Million USD | 98.109% |
| TELA Bio, Inc. | 58.45 Million USD | 95.506% |
| Treace Medical Concepts, Inc. | 187.11 Million USD | 98.596% |
| Vivos Therapeutics, Inc. | 13.8 Million USD | 80.965% |
| Acutus Medical, Inc. | 7.16 Million USD | 63.331% |
| Talis Biomedical Corporation | 412 Thousand USD | -537.621% |
| Spectral AI, Inc. | 18.05 Million USD | 85.451% |
| Nano-X Imaging Ltd. | 9.9 Million USD | 73.478% |
| CVRx, Inc. | 39.29 Million USD | 93.315% |
| DIH Holding US, Inc. Warrants | - USD | -Infinity% |
| PetVivo Holdings, Inc. | 968.7 Thousand USD | -171.187% |
| Bioventus Inc. | 512.34 Million USD | 99.487% |
| Venus Concept Inc. | 76.35 Million USD | 96.559% |
| TriSalus Life Sciences, Inc. | 18.51 Million USD | 85.808% |
| LivaNova PLC | 1.15 Billion USD | 99.772% |
| 908 Devices Inc. | 50.22 Million USD | 94.77% |
| Alphatec Holdings, Inc. | 482.26 Million USD | 99.455% |
| Nemaura Medical Inc. | 77.04 Thousand USD | -3309.74% |
| NeuroPace, Inc. | 65.42 Million USD | 95.984% |
| LENSAR, Inc. | 42.16 Million USD | 93.77% |
| Apyx Medical Corporation | 52.34 Million USD | 94.982% |
| Cutera, Inc. | 212.36 Million USD | 98.763% |
| STRATA Skin Sciences, Inc. | 33.35 Million USD | 92.125% |
| BioSig Technologies, Inc. | 18 Thousand USD | -14494.444% |
| Anika Therapeutics, Inc. | 166.66 Million USD | 98.424% |
| ClearPoint Neuro, Inc. | 23.95 Million USD | 89.034% |
| Integra LifeSciences Holdings Corporation | 1.54 Billion USD | 99.83% |
| Axonics, Inc. | 366.37 Million USD | 99.283% |
| Outset Medical, Inc. | 130.37 Million USD | 97.985% |
| IRIDEX Corporation | 51.86 Million USD | 94.935% |
| PROCEPT BioRobotics Corporation | 136.19 Million USD | 98.071% |
| IRadimed Corporation | 65.56 Million USD | 95.993% |
| Tivic Health Systems, Inc. | 1.17 Million USD | -123.384% |
| INVO Bioscience, Inc. | 3.02 Million USD | 13.03% |
| Telesis Bio, Inc. | 27.5 Million USD | 90.45% |
| Viemed Healthcare, Inc. | 183 Million USD | 98.565% |
| Varex Imaging Corporation | 811 Million USD | 99.676% |
| Quipt Home Medical Corp. | 221.74 Million USD | 98.815% |
| Inspira Technologies Oxy B.H.N. Ltd. | - USD | -Infinity% |
| Pulmonx Corporation | 68.67 Million USD | 96.175% |
| Dynatronics Corporation | 32.53 Million USD | 91.925% |
| Modular Medical, Inc. | - USD | -Infinity% |
| ReShape Lifesciences Inc. | 8.67 Million USD | 69.728% |
| Semler Scientific, Inc. | 68.18 Million USD | 96.147% |
| InMode Ltd. | 492.04 Million USD | 99.466% |
| Bruker Corporation | 2.96 Billion USD | 99.911% |
| Cytosorbents Corporation | 36.34 Million USD | 92.773% |
| DexCom, Inc. | 3.62 Billion USD | 99.927% |
| Align Technology, Inc. | 3.86 Billion USD | 99.932% |
| Viveve Medical, Inc. | 6.42 Million USD | 59.119% |
| ZimVie Inc. | 457.43 Million USD | 99.426% |
| Movano Inc. | - USD | -Infinity% |
| Cytek Biosciences, Inc. | 193.01 Million USD | 98.639% |
| Nexalin Technology, Inc. | 110.74 Thousand USD | -2272.052% |
| DIH Holdings US, Inc. Class A Common Stock | - USD | -Infinity% |
| Tandem Diabetes Care, Inc. | 747.71 Million USD | 99.649% |
| Profound Medical Corp. | 7.33 Million USD | 64.166% |
| Insulet Corporation | 1.69 Billion USD | 99.845% |
| enVVeno Medical Corporation | - USD | -Infinity% |
| Surmodics, Inc. | 126.07 Million USD | 97.916% |
| iCAD, Inc. | 17.31 Million USD | 84.831% |
| Nuwellis, Inc. | 8.86 Million USD | 70.363% |
| Biotricity, Inc. | 12.06 Million USD | 78.223% |
| iRhythm Technologies, Inc. | 492.68 Million USD | 99.467% |
| Aethlon Medical, Inc. | - USD | -Infinity% |
| InspireMD, Inc. | 6.2 Million USD | 57.663% |
| PAVmed Inc. | 2.45 Million USD | -7.137% |
| BIOLASE, Inc. | 49.16 Million USD | 94.657% |
| Beyond Air, Inc. | 1.15 Million USD | -126.661% |
| FONAR Corporation | 102.88 Million USD | 97.447% |
| AxoGen, Inc. | 159.01 Million USD | 98.348% |
| Vivani Medical, Inc. | - USD | -Infinity% |
| Tactile Systems Technology, Inc. | 274.42 Million USD | 99.043% |
| Inari Medical, Inc. | 493.63 Million USD | 99.468% |
| UFP Technologies, Inc. | 400.07 Million USD | 99.343% |
| QT Imaging Holdings, Inc. | - USD | -Infinity% |
| Heart Test Laboratories, Inc. | 18.6 Thousand USD | -14023.656% |
| Tenon Medical, Inc. | 2.92 Million USD | 10.28% |
| Autonomix Medical, Inc. Common Stock | - USD | -Infinity% |
| Co-Diagnostics, Inc. | 6.81 Million USD | 61.436% |
| AdaptHealth Corp. | 3.2 Billion USD | 99.918% |
| NanoVibronix, Inc. | 2.28 Million USD | -15.068% |
| Quanterix Corporation | 122.36 Million USD | 97.853% |
| Inspira Technologies Oxy B.H.N. Ltd. | - USD | -Infinity% |
| Sensus Healthcare, Inc. | 24.4 Million USD | 89.236% |
| Pacific Biosciences of California, Inc. | 200.52 Million USD | 98.69% |
| TransMedics Group, Inc. | 241.62 Million USD | 98.913% |
| ReWalk Robotics Ltd. | 13.85 Million USD | 81.038% |
| NeuroMetrix, Inc. | 5.9 Million USD | 55.485% |
| Hyperfine, Inc. | 11.03 Million USD | 76.187% |
| Establishment Labs Holdings Inc. | 165.15 Million USD | 98.409% |
| Biomerica, Inc. | 5.41 Million USD | 51.487% |
| Bone Biologics Corporation | - USD | -Infinity% |
| AVITA Medical, Inc. | 50.56 Million USD | 94.804% |
| Bluejay Diagnostics, Inc. | - USD | -Infinity% |
| Silk Road Medical, Inc | 177.13 Million USD | 98.517% |